🔎 Trials Near Me

Utama › Leukemia Mieloid Akut › Wisconsin › Milwaukee

Kajian klinikal Leukemia Mieloid Akut di Milwaukee, WI

17 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Milwaukee (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • dan 9 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Wisconsin, Milwaukee
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Mengambil pesertaFasa 2
  • Medical College of Wisconsin, Milwaukee
Umur 18 hingga 59 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Mengambil pesertaFasa 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Medical College of Wisconsin, Milwaukee
  • dan 12 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Mengambil pesertaFasa 2
  • Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Mengambil pesertaFasa 2
  • Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Mengambil pesertaFasa 2
  • Medical College of Wisconsin, Milwaukee
Umur 18 hingga 59 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Mengambil pesertaFasa 3
  • Children's Hospital of Wisconsin, Milwaukee
6 Months – 21 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04293562

A Study of BGB-11417 in Participants With Myeloid Malignancies

Mengambil pesertaFasa 1/2
  • Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04771130

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Mengambil pesertaFasa 3
  • Froedtert & Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • Froedtert & Medical College Clinics, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Mengambil pesertaFasa 1
  • Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06656494

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Wisconsin, Milwaukee
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Ivosidenib as Post-HSCT Maintenance for AML

Mengambil pesertaFasa 2
  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Umur 18 hingga 75 · Semua jantina · Dikemas kini 18 Jun 2026 · NCT06707493

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Mengambil pesertaFasa 2/3
  • Froedtert & Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Mengambil pesertaFasa 1
  • Medical College of Wisconsin Cancer Center, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT05735184

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Mengambil pesertaFasa 1
  • Children's Wisconsin, Milwaukee
Umur 1 hingga 25 · Semua jantina · Dikemas kini 12 Jan 2026 · NCT05317403

Kajian Leukemia Mieloid Akut di bandar lain

Kajian lain di Milwaukee

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.